Latest Conference Articles

We have to have this one voice that we've been talking about, this one consistent message.

Whether it was the ability to vaccinate, whether it was the ability to test, whether it's now the ability to prescribe Paxlovid for patients, those are big progress moves for the profession of pharmacy.

When we talk about access, that is a pharmacist.

Health Mart University also offers "basic technician training programs," to allow pharmacies to bring those new technicians on board, help them meet the PTCB examination standards, and really get that new technician ready to go.

Once the revisions to <797> become approved, there will be a minimum grace period of 6 months for pharmacies to comply.

Kevin Straughn, PharmD, clinical pharmacist at Duke Regional Hospital, said once the 2 compounding chapters, <797> and <795> become enforceable, there will be a 6-month grace period before USP <800> becomes enforceable.

Health Mart was able to deliver the targeted education they needed in a virtual manner to allow them to start in the uniting and to keep their immunization credentials.

We need to be able to build on that momentum, and at the same time, we need sustainable reimbursement models.

Health Mart University started as a platform to be franchise standards.

There's a lot of complexity in the agreements, so pharmacies like Health Mart Atlas provide reporting and resources.

Pharmacies need to kind of move beyond those models that are more punitive and look for true pharmacy-based measures and the ability to pay for performance and outcomes for patients.

Seeking personal fulfillment over money can help when assessing one’s value as a pharmacy technician.

It's really been a challenge for Health Mart pharmacies with the labor market the way that it is.

PSAO supports community pharmacies through patient access by unlocking the right payer agreements.

At the end of the day, we're interdisciplinary in terms of how it is that we need to manage our patients.

Donald Klepser, PhD, MBA, professor and dean of academic affairs at the College of Pharmacy in the University of Nebraska Medical Center, discusses how pharmacy technicians can manage their own stress and burnout.

Pharmacies are so much more attuned to being able to use that technician to the top of his or her license and credential.

We spend a lot of time harping on vaccine hesitancy, but one thing we don't talk about is vaccine access, and that is really a very key indicator to a lack of cultural competency.

Logan Franck, PharmD, BCACP, a clinical associate professor in the College of Pharmacy at the University of Nebraska Medical Center, discuses his American Association of Pharmacy Technicians session on over-the-counter medications.

It's really important that we capitalize on this time and the impact that pharmacists had to make some of this reform permanent.

If we are culturally competent, then we know the impacts of social determinants of health can have and how racism and transphobia homophobia can contribute to the social determinants of health.

Ryan Burke, PharmD, director of professional affairs at Pharmacy Technician Certification Board, discusses how the changing role of pharmacy technicians has also helped the role of the pharmacist.

Every pharmacist knows that if they don't have a well-trained technician available, they're not going to be able to do the things that were so amplified during COVID-19.

The nature of CLL being a long-term, incurable disease makes its treatment a challenge as it is more focused toward improving patient’s quality of life.

With the rapid pace of change in biosimilar payer benefit design, efforts to stay regularly updated on policy changes ahead of time become critical for patient care.

Even before the pandemic, pharmacists were playing a really important role in public health, being one of the most accessible health care providers.

Experts discuss the pros and cons of using oral azacytidine to treat patients with acute myeloid leukemia.

With a lack of head-to-head studies comparing combination regimens in frontline metastatic renal cell carcinoma, deciding on how to choose the right regimen can pose a challenge.